Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-12-12
2006-12-12
Desai, Rita (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S291000, C546S081000, C546S082000, C546S080000, C546S083000
Reexamination Certificate
active
07148232
ABSTRACT:
Thiazolo-, oxazolo- and selenazolo[4,5-c]quinolin-4-amines and analogs thereof are described including methods of manufacture and the use of novel intermediates. The compounds are immunomodulators and induce cytokine biosynthesis, including interferon and/or tumor biosynthesis, necrosis factor, and inhibit the T-helper-type 2 immune response. The compounds are further useful in the treatment of viral and neoplastic diseases.
REFERENCES:
patent: 4031230 (1977-06-01), Gottschlich et al.
patent: 4038396 (1977-07-01), Shen et al.
patent: 4131677 (1978-12-01), Shen et al.
patent: 4689338 (1987-08-01), Gerster et al.
patent: 4698348 (1987-10-01), Gerster
patent: 4778811 (1988-10-01), Knoll et al.
patent: 4904669 (1990-02-01), Knoll et al.
patent: 4929624 (1990-05-01), Gerster et al.
patent: 5037986 (1991-08-01), Gerster
patent: 5268376 (1993-12-01), Gester
patent: 5312822 (1994-05-01), Albaugh
patent: 5346905 (1994-09-01), Gerster
patent: 5352784 (1994-10-01), Nikolaides et al.
patent: 5389640 (1995-02-01), Gerster et al.
patent: 5446153 (1995-08-01), Lindstrom et al.
patent: 5451585 (1995-09-01), Albaugh
patent: 5482936 (1996-01-01), Lindstrom
patent: 5605899 (1997-02-01), Gerster et al.
patent: 0 055 248 (1982-06-01), None
patent: 2 184 117 (1987-06-01), None
patent: WO 93/05042 (1993-03-01), None
patent: WO 95/02597 (1995-01-01), None
patent: WO 95/02598 (1995-01-01), None
patent: WO 98/16514 (1998-04-01), None
patent: WO 98/42712 (1998-10-01), None
Tetrahedron Letters, vol. 22, No. 22, pp. 2121-2124, 1981 Printed in Great Britain.
Chem. Abstract 95:114500, (1981).
Chem. Abstract 86:16608, (1977).
Temple, Smith Kussner, and Montgomery, “Synthesis of Imidazo [4,5-b]pyridines and V-Triazolo [4,5-b]pyridines. Preparation of 1-Deaza-6-thioguanine Analogues”, J. Org. Chem, vol. 41, No. 24, 1976, pp. 3784-3788.
Bachman et al.,J. Org. Chem.15, 1278-1284 (1950).
Jain et al.,J. Med. Chem.11, pp. 87-92 (1968).
Baranov et al.,Chem. Abs.85, 94362 (1976).
Berenyi et al.,J. Heterocyclic Chem.18, 1537-1540 (1981).
Berge SM, et al., “Pharmaceutical Salts,”J. Pharm. Sci.1977;66:1.
Bachman et. al.,Journal of the American Chemical Society, 69, pp. 365-371 (1947).
Ambrogi et. al.,Synthesis, pp. 656-658 (1992).
Adler et. al.,Journal of the Chemical Society, pp. 1794-1797 (1960).
Süs et. al.,Justus Liebigs Annalen der Chemie, 583, pp. 150-160 (1953).
Süs et. al.,Justus Liebigs Annalen der Chemie, 593, pp. 91-126 (1955).
G. L. Brennan and L. H. Kronenberg in “Automated Bioassay of Interferons in Micro-test Plates”, Biotechniques, Jun./Jul. 78, 1983.
Testerman et. al. In “Cytokine Induction by the Immunomodulators Imiquimod and S-27609”,Journal of Leukocyte Biology, 58, 365-372 (Sep. 1995).
Korolkovas, “Essentials of Medicinal Chemistry”, 2ndEdition , John Wiley & Sons, NY, p. 78, paragraph “f”and p. 80, Table 2.9 (1988).
Gerster John F.
Lindstrom Kyle J.
Marszalek Gregory J.
Desai Rita
Ersfeld Dean
LandOfFree
Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3654342